Depression, Correlates of Depression, and Receipt of Depression Care Among Low-Income Women With Breast or Gynecologic Cancer
Authors:
- 1 May 2005
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (13) , 3052-3060
Abstract
Purpose: To assess the prevalence of depression among low-income, ethnic minority women with breast or gynecologic cancer, receipt of antidepressant medications or counseling services, and correlates of depression. Patients and Methods: Study patients were 472 women receiving cancer care in an urban public medical center. Women had a primary diagnosis of breast (stage 0 to III) or gynecologic cancer (International Federation of Gynecology and Obstetrics stage 0 to IIIB). A diagnostic depression screen and baseline questionnaire were administered before or during active treatment or during active follow-up. Self-report data were collected on receipt of depression treatment, use of supportive counseling, pain and receipt of pain medication, functional status and well-being, and perceived barriers to cancer care. Results: Twenty-four percent of women reported moderate to severe levels of depressive disorder (30% of breast cancer patients and 17% of gynecologic cancer patients). Only 12% of women meeting criteria for major depression reported currently receiving medications for depression, and only 5% of women reported seeing a counselor or participating in a cancer support group. Neither cancer stage nor treatment status was correlated with depression. Primary diagnosis of breast cancer, younger age, greater functional impairment, poorer social and family well-being, anxiety, comorbid arthritis, and fears about treatment side effects were correlated with depression. Conclusion: Findings indicate that depressive disorder among ethnic minority, low-income women with breast or gynecologic cancer is prevalent and is correlated with pain, anxiety, and health-related quality of life. Because these women are unlikely to receive depression treatment or supportive counseling, there is a need for routine screening, evaluation, and treatment in this population.Keywords
This publication has 73 references indexed in Scilit:
- Cancer and Mental Disorders in a National Community Sample: Findings from the National Comorbidity SurveyPsychotherapy and Psychosomatics, 2004
- Can oncology nurses treat depression? A pilot projectJournal of Advanced Nursing, 2004
- Psychological Distress and Cancer SurvivalPsychosomatic Medicine, 2003
- Depressive symptoms after breast cancer surgery: Relationships with global, cancer‐related, and life event stressPsycho-Oncology, 2003
- Depression as a Prognostic Factor for Breast Cancer MortalityPsychosomatics, 2003
- The PHQ-9Journal of General Internal Medicine, 2001
- Psychiatric morbidity and its recognition by doctors in patients with cancerBritish Journal of Cancer, 2001
- Relevance of Problem-Solving Therapy to Psychosocial OncologyJournal of Psychosocial Oncology, 1999
- Use of Health Care for the Treatment of Mental Problems among Racial/Ethnic SubpopulationsMedical Care Research and Review, 1997
- Depressive symptomatology of post-menopausal breast cancer patients: a comparison of women recently treated by mastectomy or by breast-conserving therapyEuropean Journal of Surgical Oncology, 1995